Pheiffer Carmen, Pillay-van Wyk Victoria, Joubert Jané D, Levitt Naomi, Nglazi Mweete D, Bradshaw Debbie
Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
Division of Medical Physiology, University of Stellenbosch, Tygerberg, South Africa.
BMJ Open. 2018 Jul 11;8(7):e021029. doi: 10.1136/bmjopen-2017-021029.
Type 2 diabetes mellitus is a major source of morbidity and mortality in South Africa, spurred by increased urbanisation and unhealthy lifestyle factors. Local epidemiological data are required to inform health planning and policy. The purpose of this systematic review is to identify, collate and synthesise all studies reporting the prevalence of diabetes in South Africa. A secondary aim is to report the prevalence of impaired glucose tolerance and impaired fasting glucose, conditions which are associated with an increased risk of progression to overt diabetes, and the prevalence of undiagnosed diabetes.
Multiple databases will be searched for diabetes prevalence studies conducted in South Africa between 1997 and 2018. Two authors will independently select studies that meet the inclusion criteria, extract data and appraise studies using a risk of bias tool for prevalence studies. Studies with low or moderate risk of bias will be included. Sources of heterogeneity will be explored using subgroup analysis.
The systematic review does not require ethics clearance since published studies with non-identifiable data will be used. This review will provide best estimates to inform the Second National Burden of Disease study which can guide health and policy planning.
CRD42017071280.
2型糖尿病是南非发病和死亡的主要原因,城市化进程加快和不健康的生活方式因素加剧了这一情况。需要当地的流行病学数据来为卫生规划和政策提供依据。本系统评价的目的是识别、整理和综合所有报告南非糖尿病患病率的研究。次要目的是报告糖耐量受损和空腹血糖受损的患病率,这些情况与进展为显性糖尿病的风险增加相关,以及未诊断糖尿病的患病率。
将检索多个数据库,查找1997年至2018年在南非进行的糖尿病患病率研究。两名作者将独立选择符合纳入标准的研究,提取数据并使用患病率研究的偏倚风险工具评估研究。将纳入偏倚风险低或中等的研究。将使用亚组分析探索异质性来源。
由于将使用已发表的、数据不可识别的研究,因此本系统评价无需伦理批准。本评价将提供最佳估计值,为第二次全国疾病负担研究提供依据,该研究可指导卫生和政策规划。
PROSPERO注册号:CRD42017071280。